🔗 Share this article

This year's Nobel Prize in medical science was granted for revolutionary discoveries that clarify how the immune system targets dangerous infections while sparing the body's own cells.

Three renowned scientists—from Japan Shimon Sakaguchi and American experts Mary Brunkow and Dr. Ramsdell—received this honor.

The work uncovered specialized "sentinels" within the defense system that remove malfunctioning defense cells capable of attacking the body.

The findings are now enabling new treatments for autoimmune diseases and cancer.

These laureates will share a prize fund valued at 11 million SEK.

Decisive Findings

"The research has been essential for comprehending how the immune system functions and why we do not all develop serious self-attack conditions," stated the head of the Nobel Committee.

This trio's research explain a core question: In what way does the immune system protect us from numerous infections while keeping our own tissues unharmed?

The body's protection system uses white blood cells that search for signs of infection, even pathogens and germs it has not met before.

Such defenders employ detectors—known as receptors—that are generated by chance in countless variations.

That gives the defense network the capacity to fight a wide array of threats, but the randomness of the process unavoidably creates immune cells that may attack the body.

Security Guards of the Immune System

Scientists previously knew that a portion of these harmful defense cells were destroyed in the immune organ—where immune cells develop.

The latest Nobel Prize recognizes the identification of regulatory T-cells—known as the body's "peacekeepers"—which travel through the body to neutralize other immune cells that assault the body's own tissues.

We know that this process malfunctions in self-attack conditions such as juvenile diabetes, multiple sclerosis, and RA.

The Nobel panel stated, "The findings have laid the foundation for a new field of research and spurred the development of new therapies, for example for tumors and immune disorders."

In malignancies, regulatory T-cells prevent the system from fighting the tumor, so research are focused on reducing their quantity.

In autoimmune diseases, trials are testing increasing regulatory T-cells so the organism is not being harmed. A similar approach could also be effective in minimizing the chances of organ transplant failure.

Pioneering Experiments

Prof Sakaguchi, of a Japanese institution, conducted tests on mice that had their immune gland removed, causing self-attack conditions.

The researcher demonstrated that injecting immune cells from healthy mice could prevent the disease—suggesting there was a system for blocking defenders from attacking the body.

Dr. Brunkow, affiliated with the a research center in a US city, and Dr. Ramsdell, now at a biotech firm in a California city, were studying an genetic immune disorder in mice and people that led to the discovery of a genetic factor vital for how T-regs operate.

"Their pioneering research has revealed how the immune system is kept in check by regulatory T cells, preventing it from accidentally targeting the body's own tissues," commented a prominent physiology specialist.

"The research is a striking example of how basic biological study can have far-reaching consequences for public health."